Literature DB >> 29766397

Novel variant of unknown significance in MUTYH in a patient with MUTYH-associated polyposis: a case to reclassify.

Trilokesh D Kidambi1, Dena Goldberg2, Robert Nussbaum3, Amie Blanco2, Sarah E Umetsu4, Jonathan P Terdiman5, Jeffrey K Lee6.   

Abstract

MUTYH-associated polyposis (MAP) is a hereditary cancer syndrome that is caused by biallelic pathogenic variants in the MUTYH gene and should be evaluated for in patients with an attenuated colonic polyposis phenotype. Monoallelic pathogenic variants in MUTYH are associated with a moderate increased risk of colorectal cancer but not with the polyposis phenotype. We present a case of a patient presenting with multiple colonic adenomatous polyps, whose germline testing revealed a heterozygous pathogenic variant in MUTYH in exon 13, c.1187G > A (p.Gly396Asp) as well as a heterozygous variant of unknown significance (VUS) in MUTYH in exon 14, c.1379T > C (p.Leu460Ser). We interpret the VUS as pathogenic in light of the patient's phenotype; the fact that the VUS was in trans with a known pathogenic variant; and because all the in silico predictors suggested, it was likely to be deleterious. This case highlights the importance of a gastroenterologist recognizing the indication for genetic testing in a patient with greater than ten adenomas, the importance of a genetic counselor in interpretation of results, and is the first report of the specific variant in the literature with clinical information to suggest that it is likely pathogenic.

Entities:  

Keywords:  Hereditary cancer syndrome; MUTYH; MYH-associated polyposis; Multiple colorectal adenomas; Polyposis

Mesh:

Substances:

Year:  2018        PMID: 29766397     DOI: 10.1007/s12328-018-0870-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  9 in total

1.  MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.

Authors:  M Morak; A Laner; U Bacher; C Keiling; E Holinski-Feder
Journal:  Clin Genet       Date:  2010-10       Impact factor: 4.438

Review 2.  Inherited colorectal cancer syndromes.

Authors:  Fay Kastrinos; Sapna Syngal
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

Review 3.  Lynch syndrome and MYH-associated polyposis: review and testing strategy.

Authors:  McKinsey Goodenberger; Noralane M Lindor
Journal:  J Clin Gastroenterol       Date:  2011-07       Impact factor: 3.062

4.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.

Authors:  Oliver M Sieber; Lara Lipton; Michael Crabtree; Karl Heinimann; Paulo Fidalgo; Robin K S Phillips; Marie-Luise Bisgaard; Torben F Orntoft; Lauri A Aaltonen; Shirley V Hodgson; Huw J W Thomas; Ian P M Tomlinson
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

5.  MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps.

Authors:  Liang Wang; Linnea M Baudhuin; Lisa A Boardman; Kelle J Steenblock; Gloria M Petersen; Kevin C Halling; Amy J French; Ruth A Johnson; Lawrence J Burgart; Kari Rabe; Noralane M Lindor; Stephen N Thibodeau
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

6.  Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability.

Authors:  V Ruggieri; E Pin; M T Russo; F Barone; P Degan; M Sanchez; M Quaia; A Minoprio; E Turco; F Mazzei; A Viel; M Bignami
Journal:  Oncogene       Date:  2012-10-29       Impact factor: 9.867

7.  Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.

Authors:  Shilpa Grover; Fay Kastrinos; Ewout W Steyerberg; E Francis Cook; Akriti Dewanwala; Lynn Anne Burbidge; Richard J Wenstrup; Sapna Syngal
Journal:  JAMA       Date:  2012-08-01       Impact factor: 56.272

8.  ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).

Authors:  Madhuri Hegde; Mathew Ferber; Rong Mao; Wade Samowitz; Arupa Ganguly
Journal:  Genet Med       Date:  2013-12-05       Impact factor: 8.822

9.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

  9 in total
  1 in total

1.  Case Report: The Role of Molecular Analysis of the MUTYH Gene in Asymptomatic Individuals.

Authors:  Katarína Fabišíková; Olívia Hamidová; Regína Lohajová Behulová; Katarína Závodná; Petra Priščáková; Vanda Repiská
Journal:  Front Genet       Date:  2020-12-15       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.